Elliot S. Friedman

The paper shows that suppressing both COX-1 and COX-2 does not cause intestinal injury in mice unless combined with specific NSAIDs, and that gut microbiome changes amplify NSAID-induced enteropathy.

This study shows that A. baumannii uses ornithine to compete with gut microbiota and persist in mice, with dietary ornithine promoting its carriage.

This study shows lactulose consumption selects for E. coli mutations that enhance its metabolic fitness and colonization, increasing infection risk in cirrhosis patients.